Last reviewed · How we verify

Ibuvix® - ibuprofen — Competitive Intelligence Brief

Ibuvix® - ibuprofen (Ibuvix® - ibuprofen) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: NSAID. Area: Oncology.

phase 2 NSAID COX-2 Oncology Small molecule Live · refreshed every 30 min

Target snapshot

Ibuvix® - ibuprofen (Ibuvix® - ibuprofen) — Apsen Farmaceutica S.A.. Inhibits COX-2 enzyme

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Ibuvix® - ibuprofen TARGET Ibuvix® - ibuprofen Apsen Farmaceutica S.A. phase 2 NSAID COX-2
Celebrex celecoxib Pfizer Inc. (originally Searle/Pharmacia) marketed Nonsteroidal Anti-inflammatory Drug [EPC] COX-2 1998-12-31
Cytotec Misoprostol Pfizer marketed NSAID combined with prostaglandin analog Cyclooxygenase (COX-1 and COX-2); Prostaglandin receptors 1988-01-01
Sumatriptan and Naproxen sodium Sumatriptan and Naproxen sodium POZEN marketed Triptan/NSAID combination 5-HT1B/1D receptors (sumatriptan); COX-1/COX-2 (naproxen sodium)
Zipsor® Zipsor® Depomed marketed NSAID (nonsteroidal anti-inflammatory drug) COX-1 and COX-2 (cyclooxygenase enzymes)
Diclofenac, topical Diclofenac, topical Nuvo Research Inc. marketed Nonsteroidal anti-inflammatory drug (NSAID) Cyclooxygenase-1 (COX-1) and Cyclooxygenase-2 (COX-2)
Intravenous ibuprofen Intravenous ibuprofen Biomendi S.A.U. marketed Nonsteroidal anti-inflammatory drug (NSAID) COX-1 and COX-2

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

Sponsor landscape (NSAID class)

  1. Antibe Therapeutics Inc. · 3 drugs in this class
  2. Iroko Pharmaceuticals, LLC · 3 drugs in this class
  3. Organon and Co · 2 drugs in this class
  4. Apsen Farmaceutica S.A. · 2 drugs in this class
  5. Amneal Pharmaceuticals, LLC · 2 drugs in this class
  6. Behar, Caren, M.D. · 2 drugs in this class
  7. IDEA AG · 2 drugs in this class
  8. Noven Pharmaceuticals, Inc. · 2 drugs in this class
  9. HALEON · 2 drugs in this class
  10. Pfizer · 2 drugs in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Ibuvix® - ibuprofen — Competitive Intelligence Brief. https://druglandscape.com/ci/ibuvix-ibuprofen. Accessed 2026-05-14.

Build your own brief

Pick any drug + add comparators: